Nancy C Andrews
Director · 4 filings · Latest: Aug 18, 2026
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Maze Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
CRL | Nancy C Andrews | Director | Aug 18, 2026 | Sale | $285.24 | 573 | $163.4K | 1,438 | |
CRL | Nancy C Andrews | Director | Aug 18, 2026 | Option Exercise | $164.30 | 573 | $94.1K | 2,011 | |
CRL | Nancy C Andrews | — | Aug 18, 2026 | Proposed Sale | $285.00 | 573 | $163.3K | — | |